Search
AbbVie Inc
ABBVAdd to Watchlist
264.480USD
+0.520+0.20%
Close 09-21 16:00（ET）
467.44BMarket Cap
130.21P/E TTM
After-hours 19:36 (ET)265.050USD+0.190+0.07%
After-hours 19:36 (ET)AbbVie Inc (ABBV) Stock Price Target & Forecast
Analyst Rating
Based on 33 analysts giving stock ratings to AbbVie Inc in the past month.
Buy
8 Strong Buy
19 Buy
6 Hold
0 Sell
0 Strong Sell
Target Price
277.312USD+5.06%
ABBV Analyst Recommendation Trends
In the current month, ABBV has received 19 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. ABBV average Analyst price target in the last month is 277.312.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
8
8
7
7
6
5
5
5
19
19
19
19
19
18
17
15
6
6
7
8
9
10
11
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33
33
33
34
34
33
33
31
ABBV Analyst Rating for Peer Comparison
Updated: Sep 21, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
Pfizer Inc
PFE
5
6
19
1
1
32
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Bristol-Myers Squibb Co
BMY
5
6
18
2
0
31
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, ABBV EPS is projected to reach 3.847 in FY2026Q3, following reported EPS of 2.036 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
2.65
2.59
3.60
3.85
3.87
Actual
1.02
0.39
2.04
--
--
Surprise
-61.51%
-85.08%
-43.52%
--
--
FAQs
What is AbbVie Inc's expected revenue for the next quarter?
AbbVie Inc's expected revenue is 17.31B.
What is AbbVie Inc's price target?
Analysts forecast that AbbVie Inc's price target is USD 277.31, with the highest forecast at USD 328.00 and the lowest forecast at USD 197.05.
How have AbbVie IncABBV's recent earnings per share performed?
The market expectation was USD 2.04, while AbbVie IncABBV's earnings per share (EPS) for the previous quarter was USD 0.39. EPS for the next quarter is expected at USD 3.85.
What is the analyst rating for AbbVie Inc?
Based on the ratings of AbbVie Inc's stock from 33 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.